Market News

2026-11-06. The following slide deck was published by Concentra Group Holdings Parent, Inc.

SEALSQ Corp. (NASDAQ:LAES) ("SEALSQ"), a company focused on quantum security technologies including secure semiconductors, Public Key Infrastr...

Susquehanna analyst Christopher Rolland maintains MACOM Technology Solns (NASDAQ:MTSI) with a Neutral and lowers the price target from $300 to $220...

Gogo (NASDAQ:GOGO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is a 120...

2026-11-06. The following slide deck was published by Enbridge Inc.

DA Davidson analyst Matt Curtis maintains Portillos (NASDAQ:PTLO) with a Neutral and raises the price target from $5 to $7.

2026-11-06. The following slide deck was published by Goldman Sachs BDC in conjunction with their 2026 Q3 earnings call.

The Nasdaq closed in correction territory as post-midterm euphoria quickly gave way to anxiety about AI spending.

U.S. stocks got routed on Thursday as midterm election results raised questions about the durability of the artificial intelligence boom.

Franklin Resources (NYSE:BEN) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.77 by 22.08 percent. This...

Small-cap stocks have benefited from a range of tailwinds this year.

Investing.com - Futures linked to the main U.S. stock indices are mixed, with the Nasdaq contract holding on to gains, as investors look to pick up th...

Gogo (NASDAQ:GOGO) affirms FY2026 sales outlook from $870.000 million-$895.000 million to $870.000 million-$895.000 million vs $886.583 million estima...

Susquehanna analyst Christopher Rolland maintains Microchip Technology (NASDAQ:MCHP) with a Positive and lowers the price target from $120 to $100.

Emera (TSX:EMA) expect to deliver 2026 adjusted EPS growth above its annual target range of 5%-7%, while maintaining its target of 5%-7% annual adjust...

BTIG analyst Jake Fuller maintains Compass (NYSE:COMP) with a Buy and lowers the price target from $15 to $13.

Policy shifts rattled wound care sales, but sequential growth hints at stabilization.

Full capacity returns, but Q4 pricing faces a sizable headwind.